Synthesis and identification of a novel tetrazole metabolite of the angiotensin Ii receptor antagonist DuP 753
Stearns, R.A.; Doss, G.A.; Miller, R.R.; Chiu, S.H.
Drug Metabolism and Disposition the Biological Fate of Chemicals 19(6): 1160-1162
1991
ISSN/ISBN: 0090-9556 PMID: 1687025 Document Number: 378497
Document emailed within 1 workday
Related Documents
Wong, P.C.; Timmermans, P.B. 1991: Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753 Journal of Pharmacology and Experimental Therapeutics 258(1): 49-57Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Huskey, S.E.; Miller, R.R.; Chiu, S.H. 1993: N-glucuronidation reactions. I. Tetrazole N-glucuronidation of selected angiotensin II receptor antagonists in hepatic microsomes from rats, dogs, monkeys, and humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(5): 792-799
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Yamaguchi, T.; Hashizume, T.; Matsuda, M.; Sakashita, M.; Fujii, T.; Sekine, Y.; Nakashima, M.; Uematsu, T. 1994: Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects Arzneimittel-Forschung 44(1): 59-64
Philips, J.C.; Weekers, L.; Scheen, A.J. 2001: Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy Revue Medicale de Liege 56(2): 126-128
Colletti, A.E.; Krieter, P.A. 1994: Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys Drug metabolism and disposition: the biological fate of chemicals 22(2): 183-188
Kondo, T.; Yoshida, K.; Yoshimura, Y.; Motohashi, M.; Tanayama, S. 1996: Disposition of the new angiotensin II receptor antagonist candesartan cilexetil in rats and dogs Arzneimittel-Forschung 46(6): 594-600
Ebisu, H.; Nishikawa, M.; Tanaka, M.; Okazoe, T.; Morizawa, Y.; Shinyama, H.; Nakamura, N. 1999: Pharmacologic profiles of GA0113, a novel quinoline derivative angiotensin II AT1-receptor antagonist Journal of Cardiovascular Pharmacology 34(4): 526-532
Milone, S.D.; Azevedo, E.R.; Forster, C.; Parker, J.D. 1999: The angiotensin II-receptor antagonist losartan does not prevent hemodynamic or vascular tolerance to nitroglycerin Journal of Cardiovascular Pharmacology 34(5): 645-650
Naka, T. 1993: Angiotensin Ii receptor antagonist activities and mode of action of benzimidazole-7-carboxylic acid derivatives Nihon Rinsho. Japanese Journal of Clinical Medicine 51(6): 1575-1579
Marchi, S.D.; Prior, M.; Zannoni, M.; Lucchese, L.; Arosio, E. 1999: Effects of an angiotensin Ii receptor antagonist (valsartan) on macro- and microcirculatory hemodynamics of the arm in hypertensive patients Minerva Cardioangiologica 47(12): 554-556
Breithaupt-Grögler, K.; Malerczyk, C.; Belz, G.G.; Butzer, R.; Herrmann, V.; Stass, H.; Wensing, G. 1997: Pharmacodynamic and pharmacokinetic properties of an angiotensin Ii receptor antagonist--characterization by use of Schild regression technique in man International Journal of Clinical Pharmacology and Therapeutics 35(10): 434-441
Sasaki, K.; Kushiro, T.; Nakagawa, S.; Kanmatsuse, K. 1999: Effects of angiotensin Ii receptor antagonist on insulin sensitivity and sympathetic activity in spontaneously hypertensive rats Nihon Jinzo Gakkai Shi 41(7): 692-696
Shibata, S.; Matsunaga, M.; Oikawa, M.; Nitahara, K.; Higa, K. 2005: Severe hypotension after induction of general anesthesia in a patient receiving an angiotensin II receptor antagonist and an alpha-blocker Masui. Japanese Journal of Anesthesiology 54(6): 670-672
Nakano, M.; Kanda, T.; Matsuzaki, S.; Hasegawa, S.; Ma, H.; Imai, S.; Suzuki, T.; Kobayashi, I. 1995: Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity Research Communications in Molecular Pathology and Pharmacology 88(1): 21-30
Miyahara, Y.; Miyazaki, T.; Tanaka, Y.; Uchida, K.; Tamura, T.; Masuda, N.; Yamashita, S.; Yonei, A. 2004: A case of intraoperative hyperkalemia induced with administration of an angiotensin II receptor antagonist (AIIA) and intake of dried persimmons Masui. Japanese Journal of Anesthesiology 53(5): 543-546
Kim, S.; Iwao, H. 1997: Involvement of angiotensin Ii in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 15(6): S3-S7
Bevan, S.; Raynes, J.G. 1991: IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells Journal of Immunology 147(8): 2574-2578
Schoepp, D.D.; Ornstein, P.L.; Leander, J.D.; Lodge, D.; Salhoff, C.R.; Zeman, S.; Zimmerman, D.M. 1990: Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action Journal of Pharmacology and Experimental Therapeutics 255(3): 1301-1308